How Rising Heart Failure Prevalence and Novel Therapeutics Are Driving the US Heart Failure Drugs Market
The US Heart Failure Drugs market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of heart failure and improve patient outcomes. The market was valued at USD 6.14 billion in 2024 and is projected to reach USD 8.14 billion by 2035, growing at a CAGR of 2.6%. The US Heart Failure...
0 Yorumlar 0 hisse senetleri 222 Views 0 önizleme